See other companies on Welcome to the Jungle

BIOS Health

Using AI & ML to translate the “language” of the nervous system

BIOS Health logo
21-100 employees
  • Healthcare
  • B2B
  • Artificial Intelligence
  • MedTech
Cambridge, UK

Company mission

BIOS Health's are on a mission to improve people's quality of life with neural engineering.

Top investors

Our take

BIOS is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.

The challenge in this field is how to collect and process large amounts of neural data and then accurately interpret the neural signals, which are incredibly noisy, continuously changing and travel throughout the body at incredible speed. In other words, a job best suited to machines underpinned by machine learning/AI.

BIOS’ neural code is built on the world’s largest proprietary neural data set and is already in use clinically to enhance data from wearables used in remote chronic disease care. This holds the key to new treatments for conditions including hypertension, diabetes, and rheumatoid arthritis, and in the future even diseases of the brain itself such as Parkinson’s or Alzheimer’s.

The plan is for BIOS to develop some products and treatments of its own, but also to partner with various companies and organisations. The premise is that the company can focus on the core interface and related AI, while the eventual applications can be as wide and vertical as advancements and interest allows.

Kirsty headshot

Kirsty

Company Specialist at Welcome to the Jungle

Benefits

  • Share options
  • Enhanced pension
  • Hybrid working
  • Flexible hours
  • Generous holiday allowance
  • Non-contributory private health insurance
  • Non-contributory private dental insurance
  • Contribution to gym membership
  • Equipment provided for home working
  • In-house CPD and allowance for professional growth
  • Annual company retreat

Company values

  • Solve the hard problems
  • Enjoy the challenge
  • Unique individuals one team
  • Respect what matters, do what's right

Funding (last 2 of 3 rounds)

Jun 2023

$20m

EARLY VC

Dec 2018

$4.5m

SEED

Total funding: $25.7m

This company has top investors

Leadership

Former University of Cambridge PhD researcher specialised in computational neuroscience and machine learning, has held leadership and technology positions in deep tech startups.

PhD in biointerfaces and tissue engineering.

Endorsements

All

Opportunities to learn (1)

Meaningful work (1)

Intelligent people (1)

BIOS Health 1BIOS Health 2BIOS Health 3BIOS Health 4BIOS Health 5BIOS Health 6